Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Gujarat hospitals to join WHO’s ‘Solidarity’ clinical trial
The trial, to be conducted by the Indian Council of Medical Research (ICMR), at hospitals in Ahmedabad, Vadodara, Surat and…
COVID-19: Dr Harsh Vardhan calls upon all scientific departments to develop enhanced synergy for…
CSIR has mounted a coordinated strategy involving all 38 CSIR labs, and is working in close coordination with the industry and…
‘We believe our effort will result in a broad-spectrum antiviral to address future outbreaks’
Dr Nir London, Senior Scientist, Department of Organic Chemistry, The Weizmann Institute of Science, has brought together a wide…
Merck accelerates readiness of bioprocessing facility of the future
Bio4C software suite, a first-of-its-kind digital ecosystem, combines process control, analytics and plant-level automation…
Lupin announces results of Phase 3 study of Single-Dose Solosec for treatment of trichomoniasis
Primary endpoint successfully achieved in Phase 3 clinical trial of 147 patients
Lupin Pharmaceuticals (Lupin) the US-based…
CPhI South East Asia rescheduled for November
Postponement to provide improved confidence and market conditions for exhibitors and visitors
CPhI South East Asia, organised…
Loadshare Networks raises Rs 100 crore to fund expansion
The startup will utilise the funds to expand its network and make a foray into new sectors like pharmaceuticals, fast-moving…
IICT develops synthetic process for Favipiravir, transfers to Cipla
As a collaborative effort with industry, Hyderabad-based CSIR-IICT transferred the entire process and significant quantities of…
Alembic Pharma gets VAI classification from USFDA for Panelav facility
The US FDA inspection was conducted from March 9-13, 2020
AIOCD requests PM to provide medical insurance to chemists, willing to pay a partial sum of premium
Around 12-14 chemists from across the country have been found COVID-19 positive of which two of them have died